Crossmark

Development and optimization of Moxifloxacin solid lipid nanoparticles via double emulsion organic solvent free technique applying Box–Behnken experimental design

Crossref DOI link: https://doi.org/10.1038/s41598-025-26860-x

Published Online: 2025-11-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elshazly, Esraa M.

Arafa, Mona G.

Nour, Samia A.
Funding

Funding for this research was provided by:

British University in Egypt
License Information

Text and Data Mining valid from 2025-11-26

Version of Record valid from 2025-11-26
More Information

Article History

Received: 15 July 2025

Accepted: 30 October 2025

First Online: 26 November 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below